Table 5 Evaluations in terms of the number of drug types in COPD group

DMFT

Min-Max (Median)

10–28 (20)

6–32 (21)

t:-0.627

Mean ± Sd

18.57 ± 5.67

19.71 ± 6.13

^⌂0.534

DMFS

Min-Max (Median)

18–130 (96)

26–220 (88)

Z:-0.214

Mean ± Sd

86.1 ± 29.66

89.14 ± 43.53

^∞0.831

G&V OHI-S

Min-Max (Median)

0.33-2 (0.75)

0.4-2 (1)

Z:-0.655

Mean ± Sd

0.87 ± 0.43

0.96 ± 0.44

^∞0.513

The amount of saliva collected (5 min)

Min-Max (Median)

2–8 (6)

1–8 (5)

Z:-0.215

Mean ± Sd

5.43 ± 1,85

5.19 ± 2.11

^∞0.830

Salivary flow rate (ml/min)

Min-Max (Median)

0.4–1.6 (1.2)

0.2–1.6 (1)

Z:-0.215

Mean ± Sd

1.09 ± 0.37

1.04 ± 0.42

^∞0.830

Buffering Capacity

Min-Max (Median)

4,5–6 (5,5)

4.5–6.5 (6)

t:0.266

Mean ± Sd

5.55 ± 0.52

5.5 ± 0.63

^⌂0.792

MS Log₁₀

Min-Max (Median)

3.95-8 (5.9)

3.95–7.9 (6)

t:0.639

Mean ± Sd

6.13 ± 0.99

5.91 ± 1.19

^⌂0.526

Levels of MS n(%)

Low

3 (14.3)

4 (19.0)

χ²:0.998

Moderate

9 (42.9)

6 (28.6)

^∩0.702

High

9 (42.9)

11 (52.4)

LB Log₁₀

Min-Max (Median)

4.3–6.6 (5)

1.95–6.15 (5)

Z:-2.018

Mean ± Sd

5.3 ± 0.62

4.64 ± 0.96

^∞0.044*

Levels of LB n(%)

Low

0 (0.0)

4 (19.0)

χ²:4.698

Moderate

10 (47.6)

6 (28.6)

^∩0.090

High

11 (52.4)

11 (52.4)

Candida albicansLog₁₀

Min-Max (Median)

0.95–4.6 (2.3)

0.95–4.9 (3.6)

Z:-0.679

Mean ± Sd

2.45 ± 1.46

2.81 ± 1.53

^∞0.497

Levels of Candida albicans

Low

12 (57.1)

8 (38.1)

χ²:1.620

Moderate

4 (19.0)

5 (23.8)

^∩0.531

High

5 (23.8)

8 (38.1)

S. aureus

n(%)

Non-carriage

20 (95.2)

19 (90.5)

χ²:0.359

Carriage

1 (4.8)

2 (9.5)

^↕1.000

Cariogram

Min-Max (Median)

32–75 (53)

35–77 (49)

t:-0.691

Mean ± Sd

53.38 ± 11.49

51 ± 10.83

^⌂0.493

Risk n(%)

Low

3 (14.3)

3 (14.3)

χ²:0.000

Mild

18 (85.7)

18 (85.7)

^↕1.000

The number of Attack n(%)

No attack

18 (85.7)

18 (85.7)

χ²:0.825

1 attack

1 (4.8)

2 (9.5)

^∩1.000

≥ 2 attacks

2 (9.5)

1 (4.8)